Author:
Zhang Mengshu,Zhao Wanwan,Zhang Zhen,He Mengting,Zhang Ya,Song Bing,Liu Jinlei,Zhang Haoqiang
Funder
Key Research Project of the Educational Department of Liaoning Province
General Program of the Department of Science & Technology of Liaoning Provinc
China Postdoctoral Science Foundation
China Endocrine Metabolism Talent Research Project
Research Funds of Center for Leading Medicine and Advanced Technologies of IHM
Chinese Cardiovascular Association-Natural lipid-lowering drugs fund
Scientific Research Start-up Funds of The First Affiliated Hospital of USTC
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.
2. Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, Shi B, Sun H, Ba J, Chen B, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997.
3. Bin Rakhis SA, Sr., AlDuwayhis NM, Aleid N, AlBarrak AN, Aloraini AA. Glycemic Control for type 2 diabetes Mellitus patients: a systematic review. Cureus. 2022;14(6):e26180.
4. Oshitari T. Advanced Glycation End-products and Diabetic Neuropathy of the Retina. Int J Mol Sci 2023;24(3).
5. Vekic J, Vujcic S, Bufan B, Bojanin D, Al-Hashmi K, Al-Rasadi K, Stoian AP, Zeljkovic A, Rizzo M. The role of Advanced Glycation End products on Dyslipidemia. Metabolites 2023;13(1).